Orchestra BioMed Holdings, Inc. Unrealized Gain (Loss) on Investments
Orchestra BioMed Holdings, Inc. (OBIO) reported Unrealized Gain (Loss) on Investments of $345.14 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-01-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2023-01-25
- Orchestra BioMed Holdings, Inc. unrealized gain (loss) on investments for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Orchestra BioMed Holdings, Inc. unrealized gain (loss) on investments for the quarter ending 2022-09-30 was $127.62K, a 3063.71% increase year-over-year.
- Orchestra BioMed Holdings, Inc. unrealized gain (loss) on investments for the quarter ending 2022-06-30 was $203.25K, a 4995.31% increase year-over-year.
- Orchestra BioMed Holdings, Inc. unrealized gain (loss) on investments for the quarter ending 2022-03-31 was $14.27K, a 261.51% increase year-over-year.
- Orchestra BioMed Holdings, Inc. unrealized gain (loss) on investments for fiscal 2022 was $345.14K, a 2056.73% increase from fiscal 2021.
- Orchestra BioMed Holdings, Inc. unrealized gain (loss) on investments for fiscal 2021 was $16.00K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 4 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 7 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-25 | $127.62K derived: sum of 2 quarters · filed 2023-01-25 | $330.88K derived: sum of 3 quarters · filed 2023-01-25 | $345.14K 10-K · filed 2023-01-25 | ||
| 2022-09-30 | $127.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $330.88K derived: sum of 2 quarters · filed 2022-11-14 | $345.14K 10-Q · filed 2022-11-14 | $349.18K derived: sum of 4 quarters · filed 2023-01-25 | ||
| 2022-06-30 | $203.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $217.52K 10-Q · filed 2022-08-15 | $221.55K derived: sum of 3 quarters · filed 2023-01-25 | $225.59K derived: sum of 4 quarters · filed 2023-01-25 | ||
| 2022-03-31 | $14.27K 10-Q · filed 2022-05-13 | $18.30K derived: sum of 2 quarters · filed 2023-01-25 | $22.33K derived: sum of 3 quarters · filed 2023-01-25 | $26.32K derived: sum of 4 quarters · filed 2023-01-25 | ||
| 2021-12-31 | $4.03K derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-25 | $8.07K derived: sum of 2 quarters · filed 2023-01-25 | $12.06K derived: sum of 3 quarters · filed 2023-01-25 | $16.00K 10-K · filed 2023-01-25 | ||
| 2021-09-30 | $4.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $8.02K derived: sum of 2 quarters · filed 2022-11-14 | $11.97K 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $3.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $7.93K 10-Q · filed 2022-08-15 | ||||
| 2021-03-31 | $3.95K 10-Q · filed 2022-05-13 | |||||
| 2020-12-31 | $6.44K 10-K/A · filed 2022-03-31 | |||||
| 2020-09-30 | $2.41K 10-Q/A · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |